Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TELEPATH: Telotristat Etiprate Extension Study
NCT02026063Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jan 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of telotristat ethyl in Carcinoid Syndrome (CS), sponsored by Lexicon Pharmaceuticals, Inc.. Started Jan 2014; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on NCT02026063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026063.